Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 3 (6), 439-459

Anti-cancer Potential of Flavonoids: Recent Trends and Future Perspectives

Affiliations

Anti-cancer Potential of Flavonoids: Recent Trends and Future Perspectives

Priya Batra et al. 3 Biotech.

Abstract

Cancer is a major public health concern in both developed and developing countries. Several plant-derived anti-cancer agents including taxol, vinblastine, vincristine, the campothecin derivatives, topotecan, irinotecan and etoposide are in clinical use all over the world. Other promising anti-cancer agents include flavopiridol, roscovitine, combretastatin A-4, betulinic acid and silvestrol. From this list one can well imagine the predominance of polyphenols, flavonoids and their synthetic analogs in the treatment of ovarian, breast, cervical, pancreatic and prostate cancer. Flavonoids present in human diet comprise many polyphenolic secondary metabolites with broad-spectrum pharmacological activities including their potential role as anti-cancer agents. A positive correlation between flavonoids-rich diet (from vegetables and fruits) and lower risk of colon, prostate and breast cancers lead to a question that whether flavonoids mediate the protective effects as chemopreventive agents or can interact with different genes and proteins to play role in chemotherapy. The current review emphasizes onto the therapeutic potential of flavonoids and their synthetic analogs as anti-cancer agents by providing new insights into the factors, regulation and molecular mechanisms along with their significant protein interactions.

Keywords: Anti-cancer; Breast cancer; Dietary flavonoids; Flavonoids; Health benefits; Therapeutic potential.

Figures

Fig. 1
Fig. 1
Subclasses of flavonoids
Fig. 2
Fig. 2
Pathway of biosynthesis of flavonoids

Similar articles

  • The Antitumor Activities of Flavonoids
    C Kandaswami et al. In Vivo 19 (5), 895-909. PMID 16097445. - Review
    The flavonoids are polyphenolic compounds found as integral components of the human diet. They are universally present as constituents of flowering plants, particularly o …
  • Cytotoxicity of Dietary Flavonoids on Different Human Cancer Types
    K Sak. Pharmacogn Rev 8 (16), 122-46. PMID 25125885. - Review
    Flavonoids are ubiquitous in nature. They are also in food, providing an essential link between diet and prevention of chronic diseases including cancer. Anticancer effec …
  • New Insights on the Anticancer Properties of Dietary Polyphenols
    P Fresco et al. Med Res Rev 26 (6), 747-66. PMID 16710860. - Review
    Cancer, one of the major causes of death across the world, has shown to be a largely preventable disease, highly susceptible to modulation by dietary factors. Phenolic co …
  • Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents
    CB Magne Nde et al. Curr Med Chem 22 (30), 3434-46. PMID 26502949. - Review
    Flavonoids are secondary metabolites abundantly present in commonly consumed fruits and vegetables. They possess diverse properties such as anti-inflammatory, anti-oxidan …
  • Modification of Flavonoid Biosynthesis in Crop Plants
    EG Schijlen et al. Phytochemistry 65 (19), 2631-48. PMID 15464151. - Review
    Flavonoids comprise the most common group of polyphenolic plant secondary metabolites. In plants, flavonoids play an important role in biological processes. Beside their …
See all similar articles

Cited by 57 PubMed Central articles

See all "Cited by" articles

References

    1. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002;3:32–40.
    1. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol-3 kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol. 1997;53(11):1649–1657. - PubMed
    1. Ahmad N, Mukhtar H. Cytochrome P450: a target for drug development for skin diseases. J Investig Dermatol. 2004;123:417–425. - PubMed
    1. Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells though inhibition of mitogen-activated-protein kinases and NF-kB. Biochem Biophys Res Commun. 2004;313:148–155. - PubMed
    1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine specific protein kinase. J Biol Chem. 1987;262:5592–5595. - PubMed

LinkOut - more resources

Feedback